Hostname: page-component-cd9895bd7-jkksz Total loading time: 0 Render date: 2024-12-18T17:46:17.769Z Has data issue: false hasContentIssue false

2181 Age-related change in 5-HT6 receptor availability in healthy male volunteers measured with 11C-GSK215083 PET

Published online by Cambridge University Press:  21 November 2018

Rajiv Radhakrishnan
Affiliation:
Yale School of Medicine, Yale University, New Haven, CT, USA
Nabeel Nabulsi
Affiliation:
Yale School of Medicine, Yale University, New Haven, CT, USA
Edward Gaiser
Affiliation:
Yale School of Medicine, Yale University, New Haven, CT, USA
Jean-Dominique Gallezot
Affiliation:
Yale School of Medicine, Yale University, New Haven, CT, USA
Shannan Henry
Affiliation:
Yale School of Medicine, Yale University, New Haven, CT, USA
Beata Planeta
Affiliation:
Yale School of Medicine, Yale University, New Haven, CT, USA
Shu-fei Lin
Affiliation:
Yale School of Medicine, Yale University, New Haven, CT, USA
Jim Ropchan
Affiliation:
Yale School of Medicine, Yale University, New Haven, CT, USA
Wendol Williams
Affiliation:
Yale School of Medicine, Yale University, New Haven, CT, USA
Evan Morris
Affiliation:
Yale School of Medicine, Yale University, New Haven, CT, USA
Deepak Cyril D’Souza
Affiliation:
Yale School of Medicine, Yale University, New Haven, CT, USA
Yiyun Huang
Affiliation:
Yale School of Medicine, Yale University, New Haven, CT, USA
Richard E. Carson
Affiliation:
Yale School of Medicine, Yale University, New Haven, CT, USA
David Matuskey
Affiliation:
Yale School of Medicine, Yale University, New Haven, CT, USA
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

OBJECTIVES/SPECIFIC AIMS: The serotonin receptor 6 (5-HT6) is a potential therapeutic target given its distribution in brain regions that are important in depression, anxiety, and cognition. This study sought to investigate the effects of age on 5-HT6 receptor availability using 11C GSK215083, a PET ligand with affinity for 5-HT6 in the striatum and 5-HT2A in the cortex. METHODS/STUDY POPULATION: In total, 28 healthy male subjects (age range: 23–52 years) were scanned with 11C-GSK215083 on the HR+PET scanner. Time-activity curves in regions-of-interest were fitted with multilinear analysis-1 method. Binding potentials (BPND) were calculated using cerebellum as the reference region and corrected for partial volume effects. RESULTS/ANTICIPATED RESULTS: In 5-HT6 rich areas, regional 11C-GSK215083 displayed a negative correlation between BPND and age in the caudate (r=−0.41, p=0.03) (14% change per decade), and putamen (r=−0.30, p=0.04) (11% change per decade), but not in the ventral striatum and pallidum. Negative correlation with age was also seen in cortical regions (r=−0.41, p=0.03) (7% change per decade), consistent with the literature on 5-HT2A availability. DISCUSSION/SIGNIFICANCE OF IMPACT: This is the first in vivo study in humans to examine the effect of age on 5-HT6 receptor availability. The study demonstrated a significant age-related decline in 5-HT6 availability (BPND) in the caudate and putamen.

Type
Basic/Translational Science/Team Science
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Association for Clinical and Translational Science 2018